Nano-hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer: A pilot study.


Journal

International wound journal
ISSN: 1742-481X
Titre abrégé: Int Wound J
Pays: England
ID NLM: 101230907

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 21 11 2019
revised: 16 12 2019
accepted: 17 12 2019
pubmed: 27 12 2019
medline: 8 1 2021
entrez: 27 12 2019
Statut: ppublish

Résumé

Wound healing, especially diabetic ones, is a relevant clinical problem, so it is not surprising that surgical procedures are often needed. To overcome invasive procedures, several strategies with drugs or natural compound are used. Recently, in an experimental study, we described an increase in keratinocyte proliferation after their exposition to quercetin plus oleic acid. In the present clinical study, we evaluated both the clinical efficacy and the safety of nano-hydrogel embedded with quercetin and oleic acid in the treatment of lower limb skin wound in patients with diabetes mellitus (DM). Fifty-six DM patients (28 men and 28 women, mean age 61.7 ± 9.2 years) unsuccessfully treated with mechanical compression were enrolled and randomised to receive an add on treatment with hyaluronic acid (0.2%) or nano-hydrogel embedded with quercetin and oleic acid. The treatment with nano-hydrogel embedded with quercetin and oleic acid significantly (P < .01) reduced the wound healing time, in comparison to hyaluronic acid (0.2%) without developing of adverse drug reactions, suggesting that this formulation could be used in the management of wound healing even if other clinical trials must be performed in order to validate this observation.

Identifiants

pubmed: 31876118
doi: 10.1111/iwj.13299
pmc: PMC7948574
doi:

Substances chimiques

Antioxidants 0
Drug Combinations 0
Hydrogels 0
Oleic Acid 2UMI9U37CP
Quercetin 9IKM0I5T1E

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

485-490

Informations de copyright

© 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Références

Eur J Pharm Biopharm. 2018 Jun;127:244-249
pubmed: 29499300
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:2-6
pubmed: 26409930
Clin Infect Dis. 2012 Jun;54(12):e132-73
pubmed: 22619242
Eur J Pharm Biopharm. 2016 Nov;108:41-53
pubmed: 27565033
N Engl J Med. 2017 Jun 15;376(24):2367-2375
pubmed: 28614678
Pharmacol Res. 2003 Jun;47(6):493-9
pubmed: 12742002
PLoS One. 2017 Jul 25;12(7):e0181499
pubmed: 28742863
Curr Drug Saf. 2009 Sep;4(3):204-6
pubmed: 19534646
Br J Community Nurs. 2019 Mar 1;24(Sup3):S14-S19
pubmed: 30817189
J Am Podiatr Med Assoc. 2017 May;107(3):180-191
pubmed: 28650752
Diabet Med. 2016 Nov;33(11):1493-1498
pubmed: 26666583
J Invest Dermatol. 2012 Jan;132(1):208-15
pubmed: 21881592
Diabetologia. 2008 May;51(5):747-55
pubmed: 18297261
Diabetes Res Clin Pract. 2017 Feb;124:84-92
pubmed: 28119194
Minerva Med. 2012 Dec;103(6):533-9
pubmed: 23229372
J Agric Food Chem. 2014 Nov 19;62(46):11146-56
pubmed: 25339414
Indian J Exp Biol. 2016 Mar;54(3):187-95
pubmed: 27145632
Adv Skin Wound Care. 2010 Jun;23(6):262-72
pubmed: 20489388
Int Wound J. 2011 Dec;8(6):567-77
pubmed: 21883937
Curr Med Res Opin. 2005 Aug;21(8):1235-40
pubmed: 16083533
J Wound Ostomy Continence Nurs. 2005 Nov-Dec;32(6):368-77
pubmed: 16301902
Int Wound J. 2020 Apr;17(2):485-490
pubmed: 31876118
J Am Podiatr Med Assoc. 2013 Jan-Feb;103(1):2-7
pubmed: 23328846
Expert Rev Anti Infect Ther. 2015 May;13(5):605-13
pubmed: 25746414
Wound Repair Regen. 2017 Aug;25(4):591-608
pubmed: 28783878
Eur J Pharm Sci. 2017 Aug 30;106:393-403
pubmed: 28636950
Pharmaceutics. 2018 Nov 03;10(4):
pubmed: 30400294
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:7-15
pubmed: 26335366
Int Wound J. 2015 Apr;12(2):179-84
pubmed: 23557025
Drug Des Devel Ther. 2014 May 13;8:519-27
pubmed: 24872682
Ann N Y Acad Sci. 2018 Jan;1411(1):153-165
pubmed: 29377202
Cell Biochem Funct. 2008 Mar-Apr;26(2):197-204
pubmed: 17918246
Wound Repair Regen. 2016 Jan-Feb;24(1):112-26
pubmed: 26663430
Clin Drug Investig. 2006;26(1):49-53
pubmed: 17163235

Auteurs

Giuseppe Gallelli (G)

Division of Vascular surgery, Department of Sugery, Pugliese Hospital, Catanzaro, Italy.

Erika Cione (E)

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.

Raffaele Serra (R)

Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.

Antonio Leo (A)

Department of Health Sciences, University of Catanzaro, Catanzaro, Italy.
Clinical Pharmacology and Pharmacovigilance Unit, Mater Domini Hospital, Catanzaro, Italy.

Rita Citraro (R)

Department of Health Sciences, University of Catanzaro, Catanzaro, Italy.
Clinical Pharmacology and Pharmacovigilance Unit, Mater Domini Hospital, Catanzaro, Italy.

Pietro Matricardi (P)

Department of Drug Chemistry and Technologies, Sapienza University of Roma, Rome, Italy.

Chiara Di Meo (C)

Department of Drug Chemistry and Technologies, Sapienza University of Roma, Rome, Italy.

Francesco Bisceglia (F)

Department of Health Sciences, University of Catanzaro, Catanzaro, Italy.
Clinical Pharmacology and Pharmacovigilance Unit, Mater Domini Hospital, Catanzaro, Italy.

Maria C Caroleo (MC)

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.

Sonia Basile (S)

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.

Luca Gallelli (L)

Department of Health Sciences, University of Catanzaro, Catanzaro, Italy.
Clinical Pharmacology and Pharmacovigilance Unit, Mater Domini Hospital, Catanzaro, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH